Bortezomib with Thalidomide or with Prednisone as Maintenance Therapy for Elderly Patients with MM: The GEM20005MAS65 Trial
Mateos MV et al. Maintenance therapy with bortezomib plus thalidomide (VT) or bortezomib plus prednisone (VP) in elderly myeloma patients included in the GEM2005MAS65 Spanish randomized trial. Proc ASH 2011;Abstract 477.
Dr Richardson is Associate Professor of Medicine at Harvard Medical School and Clinical Director of the Jerome Lipper Center for Multiple Myeloma at Dana-Farber Cancer Institute in Boston, Massachusetts.
|